2Fornoni A, Wang Y C, Lenz O, et al. Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice. J Am Soc Nephrol, 2002,13:2068-2076.
3Naito T, Razzaque MS, Nazneen A, et al. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol, 2000,11:2243-2255.
4Asanuma K, Shirato I, Ishidoh K, et al. Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int, 2002,62:822-831.
5Noel LH. Morphological features of primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant,1999,14( Suppl 3):53-57.
6McMillan J I, Riordan J W, Couser W G, et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest,1996,97:1094-1101.
7Urushihara M, Kagami S, Kuhara T, et al.Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant, 2002,17:1189-1196.
8Mundel P, Reiser J, Borja AZM ,et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res,1997, 236:248-258.
9Kriz W, Gretz N, Lemley K V. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int, 1998,54:687-697.
10Basile DP. The transforming growth factor beta sytem in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens, 1999,8:21-30.
6Dronavalli S,Duka I,Bakris G L.The pathogenesis of diabetic nephropathy[J].J Nat Clin Pract Endorinal Metab,2008,4(8):444-452.
7Nakayama S,Watada H.The impact of strict glycemic control on diabetic microangiopathy[J].Nihon Rinsho,2010,68(9):131-135.
8Singh V P,Bali A,Singh N,et al.Advanced glycation end products and diabetic complications[J].Korean J Physiol Pharmacol,2014,18(1):1-14.
9Monnier L,Mas E,Ginet C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J].JAMA,2006,95(14):1681-1687.
